Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

J&J said the U.S. expansion plan will represent a 25% increase in its investment compared to the past four years. In its annual reports, the company said it spent around $4 billion each year between ...

Leaders from across a key growth sector for the government’s upcoming industrial strategy say future UK investment is unlikely unless an unsustainable levy on manufacturers is addressed. Companies ...

Both sides of politics have vowed to stare down the Trump Administration if it goes after Australia’s $18 billion medicine subsidy scheme, after American big pharma called for the President to impose ...

Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal ...

In its fourth quarter 2024 investor letter, Polen Global Growth Strategy emphasized stocks such as ICON Public Limited Company (NASDAQ:ICLR). Headquartered in Dublin, Ireland, ICON Public Limited ...

He said Mizoram is being secretly used as a transit route by foreigners travelling to Myanmar, which has become a grave concern for the Centre. During question hour in the state assembly ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Nearly 300 Indians returned home via Thailand after being rescued from scam centers in Myanmar. A crackdown, mainly targeting Chinese-run fraud hubs, has led to the release of 7,000 workers.

Around 7,000 workers from at least two dozen countries have been freed, the majority of them Chinese, but many have been languishing in squalid conditions in temporary holding camps on the ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...